Metastatic or recurrent breast cancer

Recurrent breast cancer is breast cancer that comes back after treatment. It may return months or years later. A recurrence can be:

• Local, in the breast, chest wall, or nearby skin
• Regional, in lymph nodes near the breast, collarbone, or breastbone
• Distant, in another organ or part of the body

Distant recurrence is also called metastatic breast cancer, secondary breast cancer, or stage 4 breast cancer. Common places for breast cancer to spread include the bones, lungs, liver, and brain. The cancer cells in these places are still breast cancer cells. For example, breast cancer in a bone is not bone cancer.

Local or regional recurrence may sometimes be treated with the aim of eliminating the cancer. Metastatic breast cancer is usually not considered curable, but treatment can often control it, ease symptoms, and help people live longer.

A new diagnosis of metastatic breast cancer can also happen when breast cancer has already spread before it is first found. This is called metastatic breast cancer at initial diagnosis.

Symptoms depend on where the cancer is and how much it affects the body. Some recurrences are found during follow-up imaging before they cause symptoms.

A local or regional recurrence may cause:

• A new lump or thickened area in the breast, chest wall, or armpit
• Changes in breast or chest-wall skin
• New swelling in the breast, arm, or hand
• A change near a mastectomy scar
• Enlarged lymph nodes near the armpit or collarbone

Possible symptoms of distant spread include ongoing bone or back pain, an unexplained fracture, breathlessness, a persistent cough, abdominal swelling, reduced appetite, or yellowing of the skin or eyes.

Cancer affecting the brain may cause persistent or worsening headaches, weakness, balance problems, seizures, confusion, or changes in vision or speech.

Tiredness and unplanned weight loss can occur, but they have many other possible causes. Having one of these symptoms does not mean that breast cancer has returned. A symptom that is new, unexplained, or not improving should be assessed.

Recurrence happens when breast cancer cells survive the original treatment and later begin growing again. These cells may have remained near the original cancer or travelled elsewhere through blood or lymph vessels. They can be too small to see on scans at the time of the first treatment.

The chance of recurrence is influenced by features of the original cancer, including:

• Its size and whether lymph nodes contained cancer
• Its grade, meaning how abnormal and fast-growing the cells appeared
• Whether it had hormone receptors or excess HER2 protein
• How it responded to treatment
• Which surgery, radiation, or drug treatments were possible

Some breast cancers can return many years after the first diagnosis, especially cancers that grow in response to hormones. Others are more likely to return during the first few years.

Recurrence is not proof that someone did something wrong. It can happen even when treatment was completed exactly as planned and follow-up appointments were attended.

Assessment usually begins with a medical history, physical examination, and imaging. The scans used depend on the symptoms and suspected site. They may include mammography, ultrasound, CT, MRI, a bone scan, or PET-CT.

When possible, a biopsy is taken from the suspected recurrence. A biopsy removes a small sample for examination under a microscope. It confirms whether the area contains breast cancer rather than another condition or a new cancer.

The sample is usually tested for:

• Estrogen and progesterone receptors, which show whether hormones help the cancer grow
• HER2, a protein that can drive cancer growth
• Other gene or protein changes that may help guide treatment

These features can differ from those in the original cancer, which is one reason a new biopsy matters. If a biopsy would be unsafe or impractical, the team may make decisions using imaging and information from the original cancer.

Blood tests can check blood cell counts and how well the liver and kidneys are working. Certain blood tests called tumour markers may sometimes help monitor known metastatic cancer, but they cannot confirm or rule out recurrence by themselves.

Treatment is based on whether the recurrence is local, regional, or distant. It also considers the cancer’s receptors and gene changes, previous treatment, symptoms, organ function, rate of growth, and your priorities.

A local or regional recurrence may be treated with surgery, radiation therapy, drug treatment, or a combination. The aim may be to remove or eliminate all visible cancer when this is possible.

For metastatic breast cancer, drug treatment usually reaches cancer throughout the body. Treatment categories include:

• Hormone-blocking treatment for hormone receptor-positive cancer
• HER2-targeted treatment for HER2-positive cancer
• Chemotherapy
• Immunotherapy for some cancers
• Targeted drugs for cancers with particular gene or protein changes

Treatment is often given in stages. One treatment may continue while it is controlling the cancer and its side effects remain manageable. If it stops working or causes unacceptable problems, another may be considered.

Radiation therapy can relieve pain, reduce pressure on the spinal cord, control a tumour in the brain, or treat a particular area causing problems. Surgery is sometimes used to stabilise a weakened bone, remove a limited recurrence, or manage another specific complication.

Medicines that strengthen bone may be used when cancer has spread to bone. Pain relief, treatment for nausea, rehabilitation, and support with sleep, mood, nutrition, or mobility are also part of cancer care.

Palliative care focuses on comfort, symptoms, and quality of life. It can be provided alongside cancer treatment and does not mean that treatment is stopping.

Metastatic breast cancer can interfere with the function of the organ it affects. Bone involvement may cause pain, fractures, or high calcium levels in the blood. High calcium can lead to thirst, constipation, drowsiness, or confusion.

Cancer in the spine can press on the spinal cord. This may cause severe back pain, leg weakness, numbness, or loss of bladder or bowel control. It requires emergency assessment.

Cancer affecting the lungs or the space around them may cause breathlessness. Liver involvement can eventually affect liver function. Brain metastases may cause headaches, seizures, weakness, or changes in thinking and behaviour.

Treatment can also cause complications. These may include infection from low white blood cells, anaemia, blood clots, nerve symptoms, heart problems, fatigue, or digestive symptoms. The risks differ greatly between treatments, so the cancer team should explain what to watch for.

There is no certain way to prevent recurrent or metastatic breast cancer.

After treatment for an earlier breast cancer, surgery, radiation, hormone-blocking treatment, chemotherapy, or targeted treatment may reduce recurrence risk when they are appropriate. They cannot remove the risk completely.

Taking long-term cancer medicine as agreed can matter. If side effects make this difficult, tell the cancer team rather than stopping it without advice. A different schedule, supportive treatment, or another option may be available.

Regular physical activity, avoiding smoking, limiting alcohol, and maintaining a weight that is healthy for you can support general health. These steps do not guarantee that breast cancer will not return.

Follow-up usually includes appointments and mammograms when breast tissue remains. Routine whole-body scans are not generally used after treatment for early breast cancer when there are no symptoms, unless there is a specific reason. Report new or persistent changes rather than waiting for the next planned visit.

The course differs between local recurrence and distant spread. A local or regional recurrence may be treated intensively with the possibility of long-term control or cure. Follow-up remains important because another recurrence can still happen.

Metastatic breast cancer usually requires ongoing care over months and years. Scans, examinations, blood tests, symptoms, and side effects help show whether treatment is working. Some people have long periods when the cancer is stable. Others have cancer that changes more quickly or is harder to control.

It is common to move through several treatments over time. A change in treatment does not always mean that every option has failed. It may mean the cancer has started growing again, a side effect has become too difficult, or a more suitable treatment is available.

Daily life may include appointments, medication, and periods of tiredness or other side effects. Many people continue work, family activities, travel, and exercise, although plans may need to be adjusted around symptoms and treatment.

Uncertainty can affect sleep, relationships, finances, sexuality, and emotional health. Practical help, counselling, peer support, rehabilitation, and palliative care may all be useful. Planning for future care can sit alongside active treatment and does not remove hope or choice.

Contact your breast or cancer care team promptly about a new lump, persistent pain, increasing breathlessness, ongoing headaches, unexplained weight loss, jaundice, worsening swelling, or symptoms that do not settle.

Also seek prompt advice about treatment side effects, especially fever or signs of infection during treatment, repeated vomiting, severe diarrhoea, unusual bleeding, or being unable to keep fluids down. Follow any urgent instructions provided by your treatment centre.

Seek emergency medical care for:

• Sudden or severe difficulty breathing or chest pain
• New weakness, facial drooping, trouble speaking, or loss of balance
• A first seizure or a seizure lasting longer than expected
• Severe back pain with leg weakness, numbness, or bladder or bowel changes
• Sudden confusion, collapse, or difficulty waking
• A severe allergic reaction during or after treatment

These symptoms can have causes other than cancer, but they should not wait for a routine appointment.

Is recurrent breast cancer the same as metastatic breast cancer?

Not always. Recurrent cancer may return in the breast, chest wall, or nearby lymph nodes without spreading to distant organs. Metastatic breast cancer means it has spread to a distant site, such as bone, liver, lung, or brain.

Can metastatic breast cancer go into remission?

Yes. Treatment may produce a partial response, meaning the cancer shrinks, or a complete response, meaning no cancer is visible on current tests. This does not always mean it has been cured. Cancer cells may remain and become active again later.

How long can someone live with metastatic breast cancer?

There is no single timeline. Some cancers respond to treatment for years, while others grow more quickly. Outlook is affected by the cancer subtype, organs involved, previous treatments, general health, and response to current treatment. Population statistics cannot predict one person’s course.

Why do I need another biopsy if I already had breast cancer?

A biopsy can confirm that the new area is breast cancer. It can also show whether hormone receptors, HER2 status, or other tumour features have changed. That information may open or close particular treatment options.

Does stage 4 breast cancer mean I am dying now?

Stage 4 breast cancer is usually life-limiting, but it does not necessarily mean death is imminent. Many people receive treatment for an extended time. Your cancer team can explain what the current findings suggest while recognising that exact predictions are not possible.

Where does breast cancer spread most often?

The most common distant sites include the bones, lungs, liver, and brain. It can spread elsewhere. Symptoms and scans help determine which areas need assessment.